Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C3E0 | ISIN: KYG3871A1004 | Ticker-Symbol: 67N0
Frankfurt
27.06.25 | 08:02
0,256 Euro
-2,29 % -0,006
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
GENOR BIOPHARMA HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
GENOR BIOPHARMA HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,2460,28428.06.
0,2460,28427.06.

Aktuelle News zur GENOR BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoGENOR-B (06998): FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RELATION TO - (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER ...1
DoGENOR-B (06998): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF GENOR BIOPHARMA HOLDINGS LIMITED3
DoGENOR-B (06998): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
DoGENOR-B (06998): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025; (2) RETIREMENT OF NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN COMPOSITION ...-
13.06.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; ...1
29.05.GENOR-B (06998): VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED NEW DRUG APPLICATION APPROVAL FOR LEROCICLIB (GB491)4
27.05.GENOR-B (06998): NEXT DAY DISCLOSURE RETURN1
GENOR BIOPHARMA Aktie jetzt für 0€ handeln
26.05.GENOR-B (06998): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 501-02, 5/F, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, ...-
26.05.GENOR-B (06998): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) ...-
26.05.GENOR-B (06998): NOTICE OF ANNUAL GENERAL MEETING1
15.05.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...1
24.04.GENOR-B (06998): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
24.04.GENOR-B (06998): 2024 ANNUAL REPORT-
17.04.GENOR-B (06998): CONNECTED TRANSACTION2
15.04.GENOR-B (06998): FILING OF THE NEW LISTING APPLICATION2
24.03.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...3
18.03.GENOR-B (06998): DATE OF BOARD MEETING-
25.02.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...1
19.02.GENOR-B (06998): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 19 FEBRUARY 2025-
03.02.GENOR-B (06998): NOTICE OF EXTRAORDINARY GENERAL MEETING2
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1